KRAS and cervical carcinoma: Previous studies have implicated somatic mutations in PIK3CA (14%), PTEN (6%), TP53 (5–27%), STK11 (4%) and KRAS (8%) as well as several copy number alterations in the pathogenesis of cervical carcinomas [3, 4].